RECRUITING Phase 3 ClinicalTrials.gov

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Sponsor: Merck Sharp & Dohme LLC • ClinicalTrials.gov ID: NCT06925737

Registry updated: 2026-10-15

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if people who receive I-DXd live longer overall and live longer without the cancer growing or spreading than people who receive chemotherapy.

Interventions

Ifinatamab deruxtecan (Drug)
Administered via intravenous (IV) infusion every 3 weeks (q3w) until disease progression, unacceptable adverse events (AEs), or other cessation of treatment
Docetaxel (Drug)
Administered via IV infusion q3W until disease progression, unacceptable adverse events (AEs), or other cessation of treatment
Prednisone (Drug)
Oral tablet administered once per day or per approved product label
Rescue Medication (Drug)
Before administering each dose of I-DXd, premedication is required for prevention of nausea and vomiting with a 2 or 3 drug combination regimen (eg, corticosteroids with either a 5-HT3 receptor antagonist or an NK-1 receptor antagonist and other drugs as indicated) per approved product label

Eligibility criteria

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has histologically- or cytologically-confirmed adenocarcinoma of the prostate without small cell histology * Has prostate cancer progression while on androgen deprivation therapy (ADT) (or post bilateral orchiectomy) within 6 months prior to Screening * Has current evidence of distant metastatic disease (M1 disease) documented by either bone lesions on bone scan and/or soft tissue disease by computed tomography (CT)/magnetic resonance imaging (MRI) * Has received prior treatment with 1 or 2 androgen receptor pathway inhibitors (ARPIs) and progressed during or after at least 8 weeks of treatment * Has provided tumor tissue from a core or excisional biopsy from soft tissue not previously irradiated and obtained after disease progression on the most recent prior therapy * Has recovered from adverse events (AEs) due to previous anticancer therapies Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Is unable to swallow tablets/capsules * Has any of the following indicators of interstitial lung disease (ILD)/pneumonitis: 1. Has any history of ILD/pneumonitis that required steroid use, except for a history of radiation pneumonitis that did not require steroids 2. Has current ILD/pneumonitis 3. Has a clinical or radiographic suspicion of ILD for which the diagnosis of ILD cannot be ruled out * Has clinically severe pulmonary compromise resulting from intercurrent pulmonary illnesses * Has uncontrolled or significant cardiovascular disease * Has received prior treatment with a taxane-based chemotherapy agent for metastatic castration-resistant prostate cancer (mCRPC) * Has had prior discontinuation of an antibody drug conjugate (ADC) that consists of an exatecan derivative (eg, trastuzumab deruxtecan) due to treatment-related toxicities * Has a "superscan" bone scan

Conditions

Prostate Cancer Prostatic Neoplasms

Locations

Mayo Clinic in Arizona - Phoenix ( Site 0044) — Phoenix, Arizona, United States
Community Cancer Institute ( Site 0081) — Clovis, California, United States
City of Hope Comprehensive Cancer Center ( Site 0049) — Duarte, California, United States
City of Hope Lennar Foundation Cancer Center ( Site 0059) — Irvine, California, United States
Moores Cancer Center ( Site 0010) — La Jolla, California, United States
Veterans Affairs Long Beach Healthcare System ( Site 0058) — Long Beach, California, United States
Cedars-Sinai Medical Center ( Site 0068) — Los Angeles, California, United States
UCLA Hematology/Oncology - Santa Monica ( Site 0002) — Los Angeles, California, United States
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0006) — Orange, California, United States
Stanford Cancer Center ( Site 0046) — Palo Alto, California, United States
Rocky Mountain Regional Veterans Affairs Medical Center ( Site 0053) — Aurora, Colorado, United States
Yale-New Haven Hospital-Yale Cancer Center ( Site 0050) — New Haven, Connecticut, United States
Veterans Affairs Connecticut Healthcare System ( Site 0062) — West Haven, Connecticut, United States
The GW Medical Faculty Associates ( Site 0057) — Washington D.C., District of Columbia, United States
Washington DC Veterans Affairs Medical Center ( Site 0056) — Washington D.C., District of Columbia, United States
Clermont Oncology Center ( Site 0087) — Clermont, Florida, United States
Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0077) — Jacksonville, Florida, United States
Mid Florida Hematology and Oncology Center ( Site 0086) — Orange City, Florida, United States
Emory University School of Medicine- Grady Campus ( Site 0103) — Atlanta, Georgia, United States
Winship Cancer Institute, Emory University ( Site 0003) — Atlanta, Georgia, United States
Rush University Medical Center-Hematology and Oncology ( Site 0028) — Chicago, Illinois, United States
University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0063) — Chicago, Illinois, United States
University of Kentucky Chandler Medical Center ( Site 0048) — Lexington, Kentucky, United States
Greenebaum Comprehensive Cancer Center ( Site 0021) — Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center ( Site 0043) — Boston, Massachusetts, United States
Dana Farber Cancer Institute ( Site 0012) — Boston, Massachusetts, United States
University of Michigan ( Site 0005) — Ann Arbor, Michigan, United States
Henry Ford Hospital ( Site 0035) — Detroit, Michigan, United States
Cancer and Hematology Centers of Western Michigan ( Site 0015) — Grand Rapids, Michigan, United States
Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078) — Rochester, Minnesota, United States
HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032) — Saint Louis Park, Minnesota, United States
HealthPartners Cancer Center at Regions Hospital ( Site 0052) — Saint Paul, Minnesota, United States
St. Vincent Frontier Cancer Center-Research ( Site 0037) — Billings, Montana, United States
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island ( Site 0076) — Grand Island, Nebraska, United States
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026) — Omaha, Nebraska, United States
Comprehensive Cancer Centers of Nevada ( Site 0082) — Las Vegas, Nevada, United States
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016) — Hackensack, New Jersey, United States
University of New Mexico Comprehensive Cancer Center ( Site 0022) — Albuquerque, New Mexico, United States
Icahn School of Medicine at Mount Sinai ( Site 0009) — New York, New York, United States
Great Lakes Cancer Care ( Site 0047) — Williamsville, New York, United States
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0061) — Columbus, Ohio, United States
VA Portland Health Care System ( Site 0038) — Portland, Oregon, United States
Perelman Center for Advanced Medicine ( Site 0067) — Philadelphia, Pennsylvania, United States
Abramson Cancer Center - Penn Medicine ( Site 0079) — Philadelphia, Pennsylvania, United States
Memphis VA Medical Center ( Site 0072) — Memphis, Tennessee, United States
SCRI Oncology Partners ( Site 0074) — Nashville, Tennessee, United States
Henry-Joyce Cancer Clinic ( Site 0042) — Nashville, Tennessee, United States
Parkland Health & Hospital System ( Site 0069) — Dallas, Texas, United States
UT Southwestern Medical Center ( Site 0039) — Dallas, Texas, United States
University of Texas-MD Anderson Cancer Center ( Site 0055) — Houston, Texas, United States
Blue Ridge Cancer Care ( Site 0024) — Roanoke, Virginia, United States
VA Puget Sound Health Care System ( Site 0054) — Seattle, Washington, United States
Fred Hutchinson Cancer Center ( Site 0060) — Seattle, Washington, United States
University Hospital and UW Health Clinics ( Site 0065) — Madison, Wisconsin, United States
Medical College of Wisconsin ( Site 0008) — Milwaukee, Wisconsin, United States
Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 0136) — Berazategui, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Mar del Plata ( Site 0129) — Mar del Plata, Buenos Aires, Argentina
Instituto Alexander Fleming ( Site 0125) — Mar del Plata, Buenos Aires, Argentina
Sanatorio Parque ( Site 0126) — Rosario, Santa Fe Province, Argentina
Centro Medico Dra De Salvo ( Site 0132) — CABA, Argentina
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0131) — La Rioja, Argentina
Centro Oncologico de Integracion Regional. COIR ( Site 0130) — Mendoza, Argentina
Centro de Diagnostico Investigación y Tratamiento Oncológico (CeDIT) ( Site 0135) — Salta, Argentina
Instituto San Marcos ( Site 0137) — San Juan, Argentina
Blacktown Hospital ( Site 0154) — Blacktown, New South Wales, Australia
Macquarie University-MQ Health Clinical Trials Unit ( Site 0151) — Macquarie University, New South Wales, Australia
Gallipoli Medical Research Ltd ( Site 0153) — Greenslopes, Queensland, Australia
Peter MacCallum Cancer Centre ( Site 0152) — Melbourne, Victoria, Australia
Fiona Stanley Hospital ( Site 0155) — Murdock, Western Australia, Australia
Ordensklinikum Linz GmbH Elisabethinen-Urologie ( Site 0170) — Linz, Upper Austria, Austria
Klinikum Wels-Grieskirchen GmbH ( Site 0171) — Wels, Upper Austria, Austria
Uniklinikum Salzburg Universitaetsklinik für Innere Medizin III ( Site 0172) — Salzburg, Austria
Hospital Mario Penna ( Site 0179) — Belo Horizonte, Minas Gerais, Brazil
Hospital Universitário Evangélico Mackenzie ( Site 0181) — Curitiba, Paraná, Brazil
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0184) — Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Base de São José do Rio Preto ( Site 0176) — São José do Rio Preto, São Paulo, Brazil
IPITEC ( Site 0189) — São Paulo, Brazil
IBCC - Núcleo de Pesquisa e Ensino ( Site 0183) — São Paulo, Brazil
Fundación Arturo López Pérez ( Site 0201) — Santiago, Region M. de Santiago, Chile
Bradfordhill ( Site 0200) — Santiago, Region M. de Santiago, Chile
Peking University First Hospital ( Site 1434) — Beijing, Beijing Municipality, China
Shanghai General Hospital ( Site 1449) — Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chonqing Medical University ( Site 1406) — Chongqing, Chongqing Municipality, China
Chongqing University Three Gorges Hospital ( Site 1405) — Chongqing, Chongqing Municipality, China
The First Affiliated Hospital Of Fujian Medical University ( Site 1452) — Fuzhou, Fujian, China
Guangzhou First People's Hospital ( Site 1410) — Guangzhou, Guangdong, China
Sun Yat-Sen University Cancer Center ( Site 1467) — Guangzhou, Guangdong, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University ( Site 1402) — Guangzhou, Guangdong, China
Sun Yat-sen University Cancer Center ( Site 1409) — Guangzhou, Guangdong, China
The Fifth Affiliated Hospital of Sun Yat-Sen University ( Site 1459) — Zhuhai, Guangdong, China
Guangxi Medical University Cancer Hospital ( Site 1414) — Nanning, Guangxi, China
Henan Cancer Hospital ( Site 1472) — Zhengzhou, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1424) — Wuhan, Hubei, China
Hunan Cancer Hospital ( Site 1411) — Changsha, Hunan, China
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 1425) — Nanjing, Jiangsu, China
Jiangsu Province Hospital ( Site 1426) — Nanjing, Jiangsu, China
Zhongda Hospital Southeast University ( Site 1427) — Nanjing, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University ( Site 1438) — Xuzhou, Jiangsu, China
Jilin Province People's Hospital ( Site 1461) — Changchun, Jilin, China
The first affiliated Hospital of Xi an Jiaotong University ( Site 1408) — Xi'an, Shaanxi, China
Shandong Cancer Hospital ( Site 1421) — Jinan, Shandong, China
Shanghai Tenth People's Hospital ( Site 1441) — Shanghai, Shanghai Municipality, China
Fudan University Shanghai Cancer Center ( Site 1400) — Shanghai, Shanghai Municipality, China
Zhongshan Hospital Fudan University ( Site 1430) — Shanghai, Shanghai Municipality, China
Shanghai Tongji Hospital ( Site 1412) — Shanghai, Shanghai Municipality, China
Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1457) — Shanghai, Shanghai Municipality, China
First Affiliated Hospital Of Shanxi Medical University ( Site 1460) — Taiyuan, Shanxi, China
West China Hospital of Sichuan University ( Site 1451) — Chengdu, Sichuan, China
West China Hospital, Sichuan University ( Site 1468) — Chengdu, Sichuan, China
The Affiliated Cancer Hospital of Xinjiang Medical University ( Site 1469) — Ürümqi, Xinjiang, China
Zhejiang Cancer Hospital ( Site 1447) — Hangzhou, Zhejiang, China
The First Hospital of Jiaxing ( Site 1416) — Jiaxing, Zhejiang, China
The First Affiliated Hospital of Ningbo University ( Site 1419) — Ningbo, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University ( Site 1437) — Wenzhou, Zhejiang, China
Promotora Medica Las Americas S.A ( Site 0234) — Medellín, Antioquia, Colombia
Centro Cancerológico del Caribe (CECAC) ( Site 0227) — Barranquilla, Atlántico, Colombia
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 0229) — Bogotá, Bogota D.C., Colombia
Instituto Nacional De Cancerologia ( Site 0237) — Bogotá, Bogota D.C., Colombia
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0228) — Valledupar, Cesar Department, Colombia
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0230) — Bogota, Cundinamarca, Colombia
Oncologos Del Occidente ( Site 0231) — Pereira, Risaralda Department, Colombia
Fakultni nemocnice u sv. Anny v Brne ( Site 0264) — Brno, Brno-mesto, Czechia
Masarykuv onkologicky ustav ( Site 0260) — Brno, Brno-mesto, Czechia
Fakultni nemocnice Ostrava ( Site 0263) — Ostrava - Poruba, Moravian-Silesian Region, Czechia
Fakultni Nemocnice v Motole ( Site 0261) — Prague, Praha 5, Czechia
Fakultni nemocnice Olomouc ( Site 0262) — Olomouc, Czechia
Herlev and Gentofte Hospital ( Site 0290) — Herlev, Capital Region, Denmark
Aalborg Universitetshospital, Syd ( Site 0293) — Aalborg, North Denmark, Denmark
Odense Universitetshospital ( Site 0294) — Odense, Region Syddanmark, Denmark
Vejle Sygehus ( Site 0291) — Vejle, Region Syddanmark, Denmark
Hôpital Foch ( Site 0309) — Suresnes, Ain, France
Hopitaux Universitaires de Strasbourg- Hopital de Hautepierre ( Site 0314) — Strasbourg, Bas-Rhin, France
Hôpital Privé Clairval ( Site 0303) — Marseille, Bouches-du-Rhone, France
Centre François Baclesse ( Site 0311) — Caen, Calvados, France
CHU Besançon ( Site 0305) — Besançon, Doubs, France
Centre Hospitalier Universitaire de Nîmes - Institut de Canc-Medical Oncology ( Site 0313) — Nîmes, Gard, France
Clinique Francois Chenieux ( Site 0312) — Limoges, Haute-Vienne, France
Institut de Cancérologie de Lorraine Alexis Vautrin ( Site 0307) — Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
CHU de Rouen ( Site 0301) — Rouen, Seine-Maritime, France
Hôpital Saint-Louis ( Site 0310) — Paris, Île-de-France Region, France
Studienpraxis Urologie ( Site 0358) — Nürtingen, Baden-Wurttemberg, Germany
Klinikum Stuttgart - Katharinenhospital ( Site 0355) — Stuttgart, Baden-Wurttemberg, Germany
Klinikum der Universität München Großhadern ( Site 0366) — Munich, Bavaria, Germany
klinikum rechts der isar der technischen universität münchen ( Site 0350) — Munich, Bavaria, Germany
Klinikum Nuernberg Nord ( Site 0353) — Nuremberg, Bavaria, Germany
LOGICURO GmbH ( Site 0364) — Potsdam, Brandenburg, Germany
Universitätsklinikum Frankfurt Goethe-Universität ( Site 0354) — Frankfurt am Main, Hesse, Germany
Studienzentrum Bayenthal Urologische Partnerschaft Koln ( Site 0365) — Cologne, North Rhine-Westphalia, Germany
Urologicum Duisburg ( Site 0361) — Duisburg, North Rhine-Westphalia, Germany
Universitätsmedizin Johannes Gutenberg Universität Mainz ( Site 0362) — Mainz, Rhineland-Palatinate, Germany
Universitaetsklinikum Schleswig Holstein ( Site 0360) — Lübeck, Schleswig-Holstein, Germany
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0352) — Berlin, Germany
Universitaetsklinik Hamburg-Eppendorf ( Site 0351) — Hamburg, Germany
Henry Dunant Hospital ( Site 0385) — Athens, Attica, Greece
Metropolitan General Hospital ( Site 0382) — Athens, Attica, Greece
University General Hospital Attikon ( Site 0381) — Chaidari Athens, Attica, Greece
General Oncology Hospital of Kifisia "Agioi Anargyroi" ( Site 0384) — Kifissia, Attica, Greece
Athens Medical Center ( Site 0383) — Marousi, Attica, Greece
MEDI-K ( Site 0401) — Guatemala City, Guatemala
Med Clinic ( Site 0403) — Guatemala City, Guatemala
Onco Go ( Site 0402) — Guatemala City, Guatemala
Queen Mary Hospital ( Site 0415) — Hong Kong, Hong Kong
Tuen Mun Hospital ( Site 0416) — New Territories, Hong Kong
St Vincent's University Hospital ( Site 0441) — Dublin, Dublin, Ireland
Cork University Hospital ( Site 0442) — Cork, Ireland
Tallaght University Hospital ( Site 0440) — Dublin, Ireland
Rambam Health Care Campus ( Site 0462) — Haifa, Israel
Shaare Zedek Medical Center ( Site 0468) — Jerusalem, Israel
Meir Medical Center ( Site 0464) — Kfar Saba, Israel
Rabin Medical Center ( Site 0461) — Petah Tikva, Israel
Sheba Medical Center ( Site 0460) — Ramat Gan, Israel
Sourasky Medical Center ( Site 0463) — Tel Aviv, Israel
Yitzhak Shamir Medical Center. ( Site 0466) — Ẕerifin, Israel
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0500) — Milan, Lombardy, Italy
Istituto Clinico Humanitas ( Site 0504) — Rozzano, Milano, Italy
Istituto Nazionale Tumori Regina Elena ( Site 0507) — Rome, Roma, Italy
Azienda Ospedaliero Universitaria Senese ( Site 0505) — Siena, Tuscany, Italy
Azienda USL 8 di Arezzo ( Site 0503) — Arezzo, Italy
Humanitas Gavazzeni ( Site 0508) — Bergamo, Italy
Azienda Ospedaliero Universitaria Policlinico Riuniti di Foggia ( Site 0510) — Foggia, Italy
Azienda Ospedaliera Santa Maria Terni ( Site 0509) — Terni, Italy
Centro Ricerche Cliniche di Verona ( Site 0506) — Verona, Italy
Nagoya University Hospital ( Site 1508) — Nagoya, Aichi-ken, Japan
Toho University Sakura Medical Center ( Site 1503) — Sakura, Chiba, Japan
Ehime University Hospital ( Site 1514) — Tōon, Ehime, Japan
Hospital of the University of Occupational and Environmental Health, Japan ( Site 1510) — Kitakyushu, Fukuoka, Japan
Kurume University Hospital ( Site 1516) — Kurume, Fukuoka, Japan
Sapporo Medical University Hospital ( Site 1501) — Sapporo, Hokkaido, Japan
Hokkaido University Hospital ( Site 1500) — Sapporo, Hokkaido, Japan
Kobe University Hospital ( Site 1511) — Kobe, Hyōgo, Japan
Kanazawa Medical University Hospital ( Site 1507) — Kahoku-gun, Ishikawa-ken, Japan
Shonan Kamakura General Hospital ( Site 1530) — Kamakura, Kanagawa, Japan
Oita University Hospital ( Site 1521) — Yufu, Oita Prefecture, Japan
University of the Ryukyus Hospital ( Site 1519) — Ginowan, Okinawa, Japan
Bell Land General Hospital ( Site 1509) — Sakai, Osaka, Japan
Dokkyo Medical University Saitama Medical Center ( Site 1502) — Koshigaya, Saitama, Japan
Hamamatsu University Hospital ( Site 1520) — Hamamatsu, Shizuoka, Japan
The Jikei University Hospital ( Site 1504) — Minato, Tokyo, Japan
Tokyo Women's Medical University ( Site 1505) — Shinjuku, Tokyo, Japan
Yamaguchi University Hospital ( Site 1522) — Ube, Yamaguchi, Japan
University of Yamanashi Hospital ( Site 1506) — Chūō, Yamanashi, Japan
Harasanshin Hospital ( Site 1517) — Fukuoka, Japan
Kyushu University Hospital ( Site 1515) — Fukuoka, Japan
Gifu University Hospital ( Site 1527) — Gifu, Japan
Hiroshima University Hospital ( Site 1512) — Hiroshima, Japan
Kagoshima University Hospital ( Site 1518) — Kagoshima, Japan
Kagoshima City Hospital ( Site 1528) — Kagoshima, Japan
National Hospital Organization Kumamoto Medical Center ( Site 1524) — Kumamoto, Japan
University Hospital,Kyoto Prefectural University of Medicine ( Site 1525) — Kyoto, Japan
Nagano Municipal Hospital ( Site 1526) — Nagano, Japan
Nagasaki University Hospital ( Site 1523) — Nagasaki, Japan
Niigata Cancer Center Hospital ( Site 1529) — Niigata, Japan
Tokushima University Hospital ( Site 1513) — Tokushima, Japan
Sarawak General Hospital ( Site 0526) — Kuching, Sarawak, Malaysia
Sunway Medical Centre ( Site 0529) — Petaling Jaya, Selangor, Malaysia
Grupo Ollin Care ( Site 0544) — Pachuca, Hidalgo, Mexico
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0541) — Guadalajara, Jalisco, Mexico
Higiea Oncologia ( Site 0542) — Mexico City, Mexico City, Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0545) — Mexico City, Mexico City, Mexico
Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 0540) — Monterrey, Nuevo León, Mexico
Centro de Investigacion Clinica de Oaxaca ( Site 0543) — Oaxaca City, Oaxaca, Mexico
UMC St. Radboud ( Site 0601) — Nijmegen, Gelderland, Netherlands
Maastricht UMC+ ( Site 0612) — Maastricht, Limburg, Netherlands
VieCuri Medisch Centrum, locatie Venlo ( Site 0610) — Venlo, Limburg, Netherlands
Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 0602) — Amsterdam, North Holland, Netherlands
Tergooiziekenhuizen, locatie Hilversum ( Site 0619) — Hilversum, North Holland, Netherlands
Spaarne Gasthuis - Hoofddorp ( Site 0608) — Hoofddorp, North Holland, Netherlands
Ziekenhuisgroep Twente, locatie Almelo ( Site 0615) — Hengelo, Overijssel, Netherlands
Erasmus Medisch Centrum ( Site 0611) — Rotterdam, South Holland, Netherlands
Franciscus Gasthuis & Vlietland, Locatie Vlietland ( Site 0600) — Schiedam, South Holland, Netherlands
Haga Ziekenhuis locatie Leyweg ( Site 0607) — The Hague, South Holland, Netherlands
Meander Medisch Centrum ( Site 0604) — Amersfoort, Utrecht, Netherlands
Martini Ziekenhuis ( Site 0621) — Groningen, Netherlands
St. Antonius Ziekenhuis, locatie Utrecht ( Site 0620) — Utrecht, Netherlands
Akershus Universitetssykehus-Onkologisk avdeling ( Site 0650) — Lorenskog, Akershus, Norway
Sykehuset Innlandet HF Gjøvik ( Site 0652) — Gjøvik, Oppland, Norway
St. Olavs Hospital-Kreftklinikken ( Site 0651) — Trondheim, Sor-Trondelag, Norway
Oslo universitetssykehus, Radiumhospitalet ( Site 0653) — Oslo, Norway
Unidad de Investigacion Oncologia Clínica Piura ( Site 0669) — Castilla, Piura, Peru
Hospital Cayetano Heredia ( Site 0667) — Lima, Peru
IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0666) — Lima, Peru
Instituto Nacional de Enfermedades Neoplásicas ( Site 0665) — Lima, Peru
Instituto Neuro Cardiovascular de las Americas ( Site 0668) — Lima, Peru
Clinical Research Center Spółka z ograniczoną odpowiedzialnością MEDIC-R Sp.k ( Site 0688) — Poznan, Greater Poland Voivodeship, Poland
Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 0696) — Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Pratia MCM Krakow ( Site 0692) — Krakow, Lesser Poland Voivodeship, Poland
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 0686) — Siedlce, Masovian Voivodeship, Poland
Narodowy Instytut Onkologii im. Marii Skłodowskiej Curie ( Site 0685) — Warsaw, Masovian Voivodeship, Poland
Pratia Onkologia Katowice ( Site 0693) — Katowice, Silesian Voivodeship, Poland
National Cancer Centre Singapore ( Site 0760) — Singapore, Central Singapore, Singapore
Tan Tock Seng Hospital ( Site 0761) — Singapore, Central Singapore, Singapore
Cancercare Rondebosch Oncology ( Site 0771) — Cape Town, Gauteng, South Africa
Wits Clinical Research ( Site 0776) — Johannesburg, Gauteng, South Africa
Wilgers Oncology Centre ( Site 0775) — Pretoria, Gauteng, South Africa
Curo Oncology Centre ( Site 0779) — Pretoria, Gauteng, South Africa
LIFE GROENKLOOF ( Site 0777) — Pretoria, Gauteng, South Africa
Chonnam National University Hwasun Hospital ( Site 0794) — Hwasun Gun, Jeonranamdo, South Korea
The Catholic University of Korea St. Mary s Hospital ( Site 0795) — Seocho-gu, Seoul, South Korea
Asan Medical Center ( Site 0791) — Songpagu, Seoul, South Korea
Ulsan University Hospital ( Site 0793) — Donggu, Ulsan-Kwangyokshi, South Korea
Severance Hospital Yonsei University Health System ( Site 0790) — Seoul, South Korea
Samsung Medical Center ( Site 0792) — Seoul, South Korea
Hospital Universitario Marqués de Valdecilla ( Site 0810) — Santander, Cantabria, Spain
CHUS - Hospital Clinico Universitario ( Site 0815) — Santiago de Compostela, La Coruna, Spain
HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA ( Site 0811) — Majadahonda Madrid, Madrid, Spain
Hospital General Universitario Gregorio Marañón ( Site 0812) — Madrid, Madrid, Comunidad de, Spain
Hospital del Mar ( Site 0822) — Barcelona, Spain
Hospital Vall D Hebron ( Site 0814) — Barcelona, Spain
Hospital Universitario Reina Sofia ( Site 0816) — Córdoba, Spain
Hospital Lucus Augusti ( Site 0813) — Lugo, Spain
Hospital Universitario Quiron Madrid ( Site 0823) — Madrid, Spain
Hospital Universitario Virgen de Valme ( Site 0819) — Seville, Spain
Fundación Instituto Valenciano de Oncología ( Site 0821) — Valencia, Spain
Skånes Universitetssjukhus Malmö ( Site 0841) — Malmö, Skåne County, Sweden
Södersjukhuset ( Site 0844) — Stockholm, Stockholm County, Sweden
Karolinska Universitetssjukhuset Solna ( Site 0843) — Stockholm, Stockholm County, Sweden
Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 0840) — Uppsala, Östergötland County, Sweden
Kantonspital Aarau ( Site 0857) — Aarau, Canton of Aargau, Switzerland
University Hospital Basel ( Site 0859) — Basel, Canton of Basel-City, Switzerland
Hopitaux Universitaires de Geneve HUG. ( Site 0856) — Geneva, Canton of Geneva, Switzerland
HFR Fribourg - Hôpital Cantonal ( Site 0858) — Fribourg, Switzerland
Stadtspital Zürich Triemli ( Site 0855) — Zurich, Switzerland
National Taiwan University Hospital ( Site 0870) — Taiwan, Taipei, Taiwan
Chang Gung Medical Foundation - Kaohsiung ( Site 0872) — Kaohsiung City, Taiwan
Taichung Veterans General Hospital ( Site 0873) — Taichung, Taiwan
Taipei Veterans General Hospital ( Site 0875) — Taipei, Taiwan
Faculty of Medicine Siriraj Hospital ( Site 0885) — Bangkoknoi, Bangkok, Thailand
Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 0887) — Dusit, Bangkok, Thailand
Sakarya Egitim ve Arastırma Hastanesi ( Site 0897) — Adapazarı, Sakarya, Turkey (Türkiye)
Adana Medical Park Seyhan Hastanesi ( Site 0906) — Adana, Turkey (Türkiye)
Hacettepe Universitesi Tip Fakultesi ( Site 0895) — Ankara, Turkey (Türkiye)
Gazi University Health Research and Application Center Gazi Hospital ( Site 0903) — Ankara, Turkey (Türkiye)
Ankara Universitesi Tıp Fakultesi Hastanesi ( Site 0901) — Ankara, Turkey (Türkiye)
Istanbul Universitesi Cerrahpasa ( Site 0896) — Istanbul, Turkey (Türkiye)
Konya Necmettin Erbakan Universitesi ( Site 0905) — Konya, Turkey (Türkiye)
Addenbrooke's Hospital ( Site 0915) — Cambridge, Cambridgeshire, United Kingdom
University College London Hospital ( Site 0920) — London, Camden, United Kingdom
Royal Devon & Exeter Hospital ( Site 0924) — Exeter, Devon, United Kingdom
Queen Elizabeth Hospital Birmingham ( Site 0923) — Birmingham, England, United Kingdom
Mount Vernon Hospital ( Site 0921) — Northwood, Hillingdon, United Kingdom
St Bartholomew s Hospital ( Site 0925) — London, London, City of, United Kingdom
Royal Marsden Hospital (Sutton) ( Site 0922) — Sutton, London, City of, United Kingdom
Torbay Hospital ( Site 0918) — Devon, United Kingdom, United Kingdom

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment